Physician profile
Malcolm D Eggart
NPI 1104142223
$9,070.37
in general payments reported to CMS, 2019-2025
15 companies · $384 in 2025
The $384 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,740 · 2020: $359 · 2021: $357 · 2022: $1,092 · 2023: $3,108 · 2024: $31.24 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,375 · Food and Beverage: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,375.37 |
| Food and Beverage | $1,147.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $5,426.63 | 2019-2025 | Excelsius3d Imaging System, Mars 3v/3vl, Excelsiusgps Robotic Navigation System |
| Medtronic USA, INC. | $1,400.50 | 2019-2020 | |
| Providence Medical Technology, INC. | $1,316.92 | 2019-2022 | |
| Abbott Laboratories | $302.41 | 2019-2020 | |
| Medtronic, INC. | $214.45 | 2022-2024 | Kyphon Express II Kyphopak Tray |
| Intrinsic Therapeutics | $163.08 | 2022-2025 | Barricaid Acd (Annular Closure Device) |
| Surgalign Spine Technologies, INC. | $53.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $46.58 | 2022 | |
| Depuy Synthes Sales INC. | $40.58 | 2025 | Velys |
| Ani Pharmaceuticals, INC. | $23.84 | 2025 | Purified Cortrophin Gel |
| Lilly USA, LLC | $20.62 | 2022 | |
| Boston Scientific Corporation | $17.19 | 2024 | |
| Portola Pharmaceuticals, LLC | $16.37 | 2019 | |
| Cerapedics INC. | $13.83 | 2022 | |
| Radius Health, INC. | $13.70 | 2025 | Tymlos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malcolm Eggart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.